Efficacy Study of Pneumococcal Vaccination in Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Crohn's Disease
Interventions
DRUG

23-valent polysaccharide pneumococcal vaccine

23-valent polysaccharide pneumococcal vaccine (PSV-23 vaccine) 0.5mL single intramuscular injection

Trial Locations (15)

220-701

Yonsei University: Wonju Christian Hospital, Wŏnju

Unknown

Kosin University Gospel Hospital, Busan

Soonchunhyang University, Cheonan

Keimyung University; Dongsan Hospital, Daegu

Wonkwang University, Iksan

Asan Medical Center, Seoul

Chung-Ang University, Seoul

Ewha Womans University, Seoul

Inje University; Seoul Paik Hospital, Seoul

Konkuk University Hospital, Seoul

Korea University; Ansan Hospital, Seoul

Seoul National University Hospital, Seoul

Yonsei University; Severance Hospital, Seoul

The Catholic University of Korea; St. Vincent's Hospital, Suwon

130-702

Kyung Hee University Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Soonchunhyang University Hospital

OTHER

collaborator

Ewha Womans University

OTHER

collaborator

Kosin University Gospel Hospital

OTHER

collaborator

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

OTHER

collaborator

Inje University

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Korea University

OTHER

collaborator

Wonkwang University

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Konkuk University Hospital

OTHER

lead

Kyunghee University Medical Center

OTHER

NCT01505855 - Efficacy Study of Pneumococcal Vaccination in Crohn's Disease | Biotech Hunter | Biotech Hunter